4-aminobenzoic acid has been researched along with sphingosine kinase in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kodama, K; Kohama, T; Kono, K; Mizuno, T; Ogita, T; Tanaka, M | 1 |
Kohama, T; Kono, K; Ogita, T; Tanaka, M | 1 |
Kohama, T; Kono, K; Sugiura, M | 1 |
Ikari, S; Matsuda, H; Ochi, S; Oda, M; Sakurai, J | 1 |
Cuvillier, O; Doumerc, N; Golzio, M; Kohama, T; Malavaud, B; Naymark, M; Pchejetski, D; TeissiƩ, J; Waxman, J | 1 |
5 other study(ies) available for 4-aminobenzoic acid and sphingosine kinase
Article | Year |
---|---|
B-535a, b and c, new sphingosine kinase inhibitors, produced by a marine bacterium; taxonomy, fermentation, isolation, physico-chemical properties and structure determination.
Topics: 4-Aminobenzoic Acid; Animals; Cell-Free System; Enzyme Inhibitors; Fermentation; Gram-Negative Bacteria; Inhibitory Concentration 50; Molecular Structure; para-Aminobenzoates; Phosphotransferases (Alcohol Group Acceptor); Rats; Water Microbiology | 2000 |
Characterization of B-5354c, a new sphingosine kinase inhibitor, produced by a marine bacterium.
Topics: 4-Aminobenzoic Acid; Animals; Blood Platelets; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Inhibitory Concentration 50; Kinetics; para-Aminobenzoates; Phosphotransferases (Alcohol Group Acceptor); Rats; Structure-Activity Relationship; Substrate Specificity | 2000 |
Inhibition of recombinant sphingosine kinases by novel inhibitors of microbial origin, F-12509A and B-5354c.
Topics: 4-Aminobenzoic Acid; Benzoquinones; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Kinetics; para-Aminobenzoates; Phosphotransferases (Alcohol Group Acceptor) | 2002 |
Clostridium perfringens alpha-toxin activates the sphingomyelin metabolism system in sheep erythrocytes.
Topics: 4-Aminobenzoic Acid; ADP Ribose Transferases; Amidohydrolases; Animals; Bacterial Toxins; Botulinum Toxins; Calcium-Binding Proteins; Ceramidases; Chromatography, Thin Layer; Diglycerides; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Erythrocytes; Ethanolamines; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Hemolysis; Inositol 1,4,5-Trisphosphate; Lysophospholipids; Oleic Acids; para-Aminobenzoates; Pertussis Toxin; Phosphatidylcholines; Phosphorylcholine; Phosphotransferases (Alcohol Group Acceptor); Rabbits; Sheep; Sphingomyelins; Sphingosine; Time Factors; Toxins, Biological; Type C Phospholipases | 2004 |
Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models.
Topics: 4-Aminobenzoic Acid; Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Caspases; Cell Line, Tumor; Cell Survival; Ceramides; Drug Therapy, Combination; Green Fluorescent Proteins; Humans; Irinotecan; Lysophospholipids; Male; Mice; Neoplasm Metastasis; para-Aminobenzoates; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Sphingosine; Treatment Outcome; Xenograft Model Antitumor Assays | 2008 |